Evidence map›Paper›PMID 20702413›Full record

ArticleThe Journal of biological chemistry2010

A novel pathway for inducible nitric-oxide synthase activation through inflammasomes.

Carina L Buzzo, Julia C Campopiano, Liliana M Massis, Silvia L Lage, Alexandra A Cassado, Rafael Leme-Souza, Larissa D Cunha, Momtchilo Russo, Dario S Zamboni, Gustavo P Amarante-Mendes and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. São Paulo School of Advanced Sciences on Vaccines: an overview.The journal of venomous animals and toxins including tropical diseases · 2020
    Review
  9. Article
  10. Article
  11. Article
  12. Post-translational regulation of inflammasomes.Cellular & molecular immunology · 2017
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Cytosolic flagellin-induced lysosomal pathway regulates inflammasome-dependent and -independent macrophage responses.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Carina L BuzzoDepartamento de Imunologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo 05508-900, Brazil.
Julia C Campopiano
Liliana M Massis
Silvia L Lage
Alexandra A Cassado
Rafael Leme-Souza
Larissa D Cunha
Momtchilo Russo
Dario S Zamboni
Gustavo P Amarante-Mendes
Karina R Bortoluci
Universidade de São Paulo · BRUniversidade de Ribeirão Preto · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Innate immune recognition of flagellin is shared by transmembrane TLR5 and cytosolic Nlrc4 (NOD-like receptor family CARD (caspase activation recruitment domain) domain containing 4)/Naip5 (neuronal apoptosis inhibitory protein 5). TLR5 activates inflammatory genes through MYD88 pathway, whereas Nlrc4 and Naip5 assemble multiprotein complexes called inflammasomes, culminating in caspase-1 activation, IL-1β/IL-18 secretion, and pyroptosis. Although both TLR5 and Naip5/Nlrc4 pathways cooperate to clear infections, little is known about the relative anti-pathogen effector mechanisms operating through each of them. Here we show that the cytosolic flagellin (FLA-BSDot) was able to activate iNOS, an enzyme previously associated with TLR5 pathway. Using Nlrc4- or Naip5-deficient macrophages, we found that both receptors are involved in iNOS activation by FLA-BSDot. Moreover, distinct from extracellular flagellin (FLA-BS), iNOS activation by intracellular flagellin is completely abrogated in the absence of caspase-1. Interestingly, IL-1β and IL-18 do not seem to be important for FLA-BSDot-mediated iNOS production. Together, our data defined an additional anti-pathogen effector mechanism operated through Naip5 and Nlrc4 inflammasomes and illustrated a novel signaling transduction pathway that activates iNOS.

Indexed as

AnimalsApoptosis Regulatory ProteinsCalcium-Binding ProteinsEnzyme ActivationFemaleFlagellinImmunity, InnateInflammationInterleukin-18Interleukin-1betaMacrophagesMiceMice, Inbred C57BLMice, KnockoutMultiprotein ComplexesMyeloid Differentiation Factor 88Apoptosis Regulatory ProteinsCalcium-Binding ProteinsFlagellinInterleukin-18Interleukin-1betaIpaf protein, mouseMultiprotein ComplexesMyd88 protein, mouseMyeloid Differentiation Factor 88Naip5 protein, mouseNeuronal Apoptosis-Inhibitory ProteinNitric Oxide Synthase Type IIToll-Like Receptor 5

Identifiers

PMID20702413
PMCPMC2952210
OpenAlexW2020458505

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.